BioMed Research International

Advances in Colorectal Cancer


Publishing date
29 Apr 2016
Status
Published
Submission deadline
11 Dec 2015

1University of Athens, Athens, Greece

2Imperial College London, London, UK

3Stadtspital Triemli, Zürich, Switzerland


Advances in Colorectal Cancer

Description

Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. Surgery remains the cornerstone for curative treatment, and operative techniques have changed considerably over the past decades. Laparoscopic approach has become standard for colon cancer, and several developments including robotic-assisted surgery are evolving for rectal cancer. The addition of targeted therapies has prolonged life in metastatic disease to considerable extent. The genetic understanding of the disease has led to introduction of molecular classification proposals, which exemplifies knowledge translated from basic science to clinical care. Furthermore, the advance of currently available diagnostic modalities and the experimental investigation of novel technologies such as the implementation of nanoparticles brings considerable promise for the detection, staging, and treatment of CRC and calls for improved stratification and prognostication to better allocate resources and justify associated costs while reducing morbidity and even mortality from the disease.

A new wave of trial data in the coming years and an evolving knowledge of relevant biomarkers may bring us closer to new more effective screening and surveillance strategies. To best apply these insights, a number of important research questions need to be addressed, and new decision making tools must be developed. To promote the basic and clinical research field in CRC, we invite investigators to contribute original research articles as well as review articles that will stimulate continuing efforts to expand the diagnosis and treatment of CRC.

Potential topics include, but are not limited to:

  • Incidence, screening, and risk factors
  • Genetics and heredity
  • Molecular basis of cancer
  • Advances in endoscopy
  • Novel diagnostic approaches including biomarkers, serology, and imaging
  • Surgery and postoperative management
  • Nanoparticles and nanomaterials
  • Novel modalities in chemotherapy
  • Recurrence and metastasis
  • Cost effectiveness of current and/or future strategies

Articles

  • Special Issue
  • - Volume 2016
  • - Article ID 7347648
  • - Editorial

Advances in Colorectal Cancer

Nikolaos I. Nikiteas | Markus Weber | ... | Dimitrios Dimitroulis
  • Special Issue
  • - Volume 2016
  • - Article ID 6896024
  • - Review Article

Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options

Daniela Rodrigues | Adhemar Longatto-Filho | Sandra F. Martins
  • Special Issue
  • - Volume 2016
  • - Article ID 9328250
  • - Review Article

Simultaneous Minimally Invasive Treatment of Colorectal Neoplasm with Synchronous Liver Metastasis

Stefano Garritano | Federico Selvaggi | Marcello Giuseppe Spampinato
  • Special Issue
  • - Volume 2016
  • - Article ID 6830713
  • - Research Article

Cost-Effectiveness between Double and Single Fecal Immunochemical Test(s) in a Mass Colorectal Cancer Screening

Shan-Rong Cai | Hong-Hong Zhu | ... | Shu Zheng
  • Special Issue
  • - Volume 2016
  • - Article ID 7590245
  • - Review Article

Advances of Targeted Therapy in Treatment of Unresectable Metastatic Colorectal Cancer

Suk-young Lee | Sang Cheul Oh
  • Special Issue
  • - Volume 2016
  • - Article ID 8208904
  • - Research Article

Expression of Migration-Related Genes in Human Colorectal Cancer and Activity of a Disintegrin and Metalloproteinase 17

Katarzyna Walkiewicz | Paweł Kozieł | ... | Małgorzata Muc-Wierzgoń
  • Special Issue
  • - Volume 2016
  • - Article ID 8412071
  • - Research Article

Does the Gadoxetic Acid-Enhanced Liver MRI Impact on the Treatment of Patients with Colorectal Cancer? Comparison Study with 18F-FDG PET/CT

Ji-Won Oh | Soon Nam Oh | ... | Seong Taek Oh
BioMed Research International
 Journal metrics
See full report
Acceptance rate8%
Submission to final decision110 days
Acceptance to publication24 days
CiteScore5.300
Journal Citation Indicator-
Impact Factor-
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.